Results 51 to 60 of about 208,963 (249)
Mucosal relapse of visceral leishmaniasis in a child treated with anti-TNFα
International Journal of Infectious Diseases, 2015 Visceral leishmaniasis is an enzootic parasitosis present across the Mediterranean Basin. Some consider it an opportunistic parasite. We report the case of a girl treated with anti-tumour necrosis factor alpha (anti-TNFα) for juvenile idiopathic ...
E. Jeziorski +6 more
doaj +1 more source
Current Visceral Leishmaniasis Research: A Research Review to Inspire Future Study
BioMed Research International, 2018 Visceral leishmaniasis (VL), one of the deadliest parasitic diseases in the world, causes more than 50,000 human deaths each year and afflicts millions of people throughout South America, East Africa, South Asia, and Mediterranean Region.
Kaiming Bi +4 more
semanticscholar +1 more source
Treatment of Visceral Leishmaniasis
Archives of Pediatrics & Adolescent Medicine, 1992 Sir .—Mahieu and Van Acker 1 reported a case of visceral leishmaniasis (kalaazar) in the November 1991 issue of AJDC . Several case reports were included in the references, but only a few were from Mediterranean countries in which the disease is more prevalent, as mentioned by the authors. I would like to bring our experience with this disease into the
openaire +5 more sources
Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report
Revista da Sociedade Brasileira de Medicina TropicalVisceral leishmaniasis is common in Brazil and is caused by Leishmania (Leishmania) infantum/chagasi. Post-kala-azar dermal leishmaniasis frequently follows visceral leishmaniasis caused by L.
José Angelo Lauletta Lindoso +5 more
doaj +1 more source
Non-Leishmania Parasite in Fatal Visceral Leishmaniasis–Like Disease, Brazil
Emerging Infectious Diseases, 2019 Through whole-genome sequencing analysis, we identified non-Leishmania parasites isolated from a man with a fatal visceral leishmaniasis–like illness in Brazil. The parasites infected mice and reproduced the patient’s clinical manifestations.
S. Maruyama +14 more
semanticscholar +1 more source
Congenital Visceral Leishmaniasis
Emerging Infectious Diseases, 2006 To the Editor: Visceral leishmaniasis (VL) is usually transmitted by phlebotomine sandflies. Nonvector transmission occasionally occurs through blood transfusions, contaminated needles of drug users, organ transplants, or laboratory infection (1). Only a few cases of congenital transmission have been reported.
Erna Fleischmann +5 more
openaire +2 more sources
Visceral leishmaniasis and HIV coinfection: current perspectives
HIV/AIDS, 2018 Visceral leishmaniasis (VL) is caused by Leishmania donovani and Leishmania infantum. The burden of VL is concentrated in tropical and subtropical areas; however, HIV infection has spread VL over a hyperendemic area.
J. Lindoso +3 more
semanticscholar +1 more source
Antileishmanial Activities of Carvacrol Nanoencapsulate in Biopolymeric Nanoparticles
Chemistry &Biodiversity, EarlyView.The study obtained biopolymeric nanoparticles containing carvacrol (NPCar) and evaluated their anti‐leishmanial activity. NPCar obtained presented physicochemical characteristics due to its ideal nanometric size and zeta potential, and low polydispersity index.
Joyce Cordeiro Borges +6 more
wiley +1 more source
Development of a LAMP assay for detection of Leishmania infantum infection in dogs using conjunctival swab samples [PDF]
, 2015 Background: Leishmania infantum infections in dogs play a crucial role in the transmission of pathogens causing visceral leishmaniasis to humans in the Gansu province, northwest China. To be able to control zoonotic transmission of the parasite to humans,
A Moshfe +48 more
core +1 more source
PLoS ONE, 2019 Visceral leishmaniasis (VL) or kala-azar, the most severe form of leishmaniasis, can lead to death if not properly diagnosed and treated. Correct identification of infected patients and reservoirs is vital for controlling the spread of leishmaniasis ...
L. Dhom-Lemos +12 more
semanticscholar +1 more source